Greenwich Wealth Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $780K | Sell |
|
|||||
|
2025
Q1 | $846K | Sell |
|
|||||
|
2024
Q4 | $988K | Sell |
|
|||||
|
2024
Q3 | $1.11M | Sell |
|
|||||
|
2024
Q2 | $1.07M | Buy |
|
|||||
|
2024
Q1 | $990K | Sell |
|
|||||
|
2023
Q4 | $1.02M | Buy |
|
|||||
|
2023
Q3 | $825K | Sell |
|
|||||
|
2023
Q2 | $957K | Buy |
|
|||||
|
2023
Q1 | $843K | Buy |
|
|||||
|
2022
Q4 | $845K | Sell |
|
|||||
|
2022
Q3 | $814K | Buy |
|
|||||
|
2022
Q2 | $742K | Buy |
|
|||||
|
2022
Q1 | $810K | Buy |
|
|||||
|
2021
Q4 | $823K | Buy |
|
|||||
|
2021
Q3 | $792K | Sell |
|
|||||
|
2021
Q2 | $861K | Sell |
|
|||||
|
2021
Q1 | $951K | Buy |
|
|||||
|
2020
Q4 | $978K | Sell |
|
|||||
|
2020
Q3 | $868K | Buy |
|
|||||
|
2020
Q2 | $848K | Sell |
|
|||||
|
2020
Q1 | $885K | Sell |
|
|||||
|
2019
Q4 | $1.11M | Sell |
|
|||||
|
2019
Q3 | $906K | Sell |
|
|||||
|
2019
Q2 | $1.1M | Buy |
|
|||||
|
2019
Q1 | $1.01M | Sell |
|
|||||
|
2018
Q4 | $816K | Buy |
|
|||||
|
2018
Q3 | $1.06M | Buy |
|
|||||
|
2018
Q2 | $1.03M | Sell |
|
|||||
|
2018
Q1 | $954K | Buy |
|
|||||
|
2017
Q4 | $904K | Sell |
|
|||||
|
2017
Q3 | $929K | Buy |
|
|||||
|
2017
Q2 | $812K | Buy |
|
|||||
|
2017
Q1 | $500K | Buy |
|
|||||
|
2016
Q4 | $312K | Sell |
|
|||||
|
2016
Q3 | $377K | Buy |
|
|||||
|
2016
Q2 | $286K | Sell |
|
|||||
|
2016
Q1 | $275K | Buy |
|